175 related articles for article (PubMed ID: 19669866)
1. Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces.
Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; Witkamp GJ; Duszczyk J
J Mater Sci Mater Med; 2010 Jan; 21(1):215-21. PubMed ID: 19669866
[TBL] [Abstract][Full Text] [Related]
2. Size effect of PLGA spheres on drug loading efficiency and release profiles.
Dawes GJ; Fratila-Apachitei LE; Mulia K; Apachitei I; Witkamp GJ; Duszczyk J
J Mater Sci Mater Med; 2009 May; 20(5):1089-94. PubMed ID: 19160026
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.
Son JS; Choi YA; Park EK; Kwon TY; Kim KH; Lee KB
J Biomed Mater Res B Appl Biomater; 2013 Feb; 101(2):247-57. PubMed ID: 23143817
[TBL] [Abstract][Full Text] [Related]
4. Drug release from PLGA microspheres attached to solids using supercritical CO₂.
Mulia K; Witkamp GJ; Dawes GJ; Fratila-Apachitei LE; Apachitei I; Duszczyk J; Pellikaan H
J Biomater Appl; 2011 Jan; 25(5):401-12. PubMed ID: 20042430
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexamethasone-loaded PLGA microspheres on human fetal osteoblasts.
Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; van Leeuwen JP; Duszczyk J; Eijken M
J Biomater Appl; 2012 Nov; 27(4):477-83. PubMed ID: 21862514
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
[TBL] [Abstract][Full Text] [Related]
9. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.
Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635
[TBL] [Abstract][Full Text] [Related]
10. Development of a sustained-release system for perivascular delivery of dipyridamole.
Zhu W; Masaki T; Bae YH; Rathi R; Cheung AK; Kern SE
J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):135-43. PubMed ID: 16206204
[TBL] [Abstract][Full Text] [Related]
11. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
12. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
[TBL] [Abstract][Full Text] [Related]
13. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.
Kazazi-Hyseni F; Landin M; Lathuile A; Veldhuis GJ; Rahimian S; Hennink WE; Kok RJ; van Nostrum CF
Pharm Res; 2014 Oct; 31(10):2844-56. PubMed ID: 24825756
[TBL] [Abstract][Full Text] [Related]
14. Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis.
Jiang T; Petersen RR; Call G; Ofek G; Gao J; Yao JQ
J Biomed Mater Res B Appl Biomater; 2011 May; 97(2):355-63. PubMed ID: 21442745
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
16. Osseointegration of anodized titanium implants coated with poly(lactide-co-glycolide)/basic fibroblast growth factor by electrospray.
Lee SY; Koak JY; Heo SJ; Kim SK; Lee SJ; Nam SY
Int J Oral Maxillofac Implants; 2010; 25(2):315-20. PubMed ID: 20369090
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
18. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
[TBL] [Abstract][Full Text] [Related]
19. Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method.
Nah JW; Paek YW; Jeong YI; Kim DW; Cho CS; Kim SH; Kim MY
Arch Pharm Res; 1998 Aug; 21(4):418-22. PubMed ID: 9875469
[TBL] [Abstract][Full Text] [Related]
20. Novel bioresorbable stent coating for drug release in congenital heart disease applications.
Goodfriend AC; Welch TR; Barker G; Ginther R; Riegel MS; Reddy SV; Wang J; Nugent A; Forbess J
J Biomed Mater Res A; 2015 May; 103(5):1761-70. PubMed ID: 25196819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
